Isoproterenol
Isoproterenol is a pharmaceutical drug with 14 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
4
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
POTS Adrenergic Ab (CIHR Aims #1&2)
Early Neurovascular Adaptations in Aging Women
Autoimmune Basis for Postural Tachycardia Syndrome
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Clinical Trials (14)
POTS Adrenergic Ab (CIHR Aims #1&2)
Early Neurovascular Adaptations in Aging Women
Autoimmune Basis for Postural Tachycardia Syndrome
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
Augmented Interoceptive Exposure Training in Anorexia Nervosa
Chronotropic Incompetence in Patients With HFpEF
Decision Support for Intraoperative Low Blood Pressure
Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation
Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol
Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms
Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract
Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14